Geoffrey Raymond Oxnard
CIK: 0002144320
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BLSM
BlossomHill Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Oxnard Geoffrey Raymond
Oxnard Geoffrey Raymond (SEC CIK 0002144320) files insider reports with the SEC as Chief Medical Officer of BlossomHill Therapeutics, Inc. (BLSM).
Signal8 holds 2 ownership filings by Oxnard Geoffrey Raymond (1 Form 3, 1 Form 4), filed between Aug 6, 2026 and Aug 10, 2026. Those filings report 1 transaction, the latest on Aug 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Oxnard Geoffrey Raymond's filings is in SAN DIEGO, CA.
Recent filings by Oxnard Geoffrey Raymond
- Aug 6, 2026: Grant or award of BLSM derivative securities (Form 4, code A).
Other insiders filing for BlossomHill Therapeutics, Inc. (BLSM)
- GORDON CARL L, Director
- ORBIMED ADVISORS LLC, Director
- Schmid John P., Director
- Chen Bihua, Director
- Agrawal Sundeep, Director
- Keyes Jason A, Chief Financial Officer